Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ITMCTR2026000424) titled 'A Study on the Clinical Efficacy and Relationship with Brain Function of Compound Cistanche Intellect Capsules in Regulating the "Nephroencephalic Axis" and "Hepatoencephalic Axis" for the Treatment of Mild to Moderate Alzheimer's Disease' on Feb. 25.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Tongde Hospital of Zhejiang Province

Condition: Alzheimer's Disease

Intervention: Experimental Group:Compound Cistanche Intellecti-boosting Capsules 0.3g per capsule, 4 capsules each time, orally, 3 times daily

Recruitment Status: Not Recruiting

Phase: Others

Date of First Enrollme...